# Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Recovery in Patients Undergoing Major Abdominal Surgery

> **NCT07651722** · NA · RECRUITING · sponsor: **Tianjin First Central Hospital** · enrollment: 132 (estimated)

## Conditions studied

- Postoperative Pain
- Postoperative Ileus

## Interventions

- **DRUG:** ropivacaine hydrochloride
- **DRUG:** Liposomal bupivacaine (LB)
- **DRUG:** Sufentanil citrate
- **DRUG:** oxycodone

## Key facts

- **NCT ID:** NCT07651722
- **Lead sponsor:** Tianjin First Central Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-16
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07651722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07651722, "Effect of Liposomal Bupivacaine TAPB Combined With Oxycodone PCIA on Postoperative Gastrointestinal Recovery in Patients Undergoing Major Abdominal Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07651722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*